6634 Federal Register / Vol. 65, No. 28 / Thursday, February 10, 2000 / Notices

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated October 8, 1999, and

published in the Federal Register on

October 18, 1999, (64 FR 52266), Chirex

Technology Center, Inc., DBA Chirex

Cauldron, 383 Phoenixville Pike,

Malvern, Pennsylvania 19355, made

application to the Drug Enforcement

Administration (DEA) to be registered as

an importer of phenylacetone (8501), a

basic class of controlled substance listed

in Schedule II.

The firm plans to import the

phenylacetone for the manufacture of

amphetamine. No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and 952(a), and

determined that the registration of

Chirex Technology Center, Inc., DBA

Chirex Cauldron to import

phenylacetone is consistent with the

public interest and with United States

obligations under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. DEA has

investigated the company to ensure that

the company’s registration is consistent

with the public interest. This

investigation included inspection and

testing of the company’s physical

security systems, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to Section 1008(a)

of the Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations, Section

1301.34, the above firm is granted

registration as an importer of the basic

class of controlled substance listed

above.

Dated: January 27, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–3144 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.33(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on November 29,

1999, Ganes Chemicals Inc., Industrial

Park Road, Pennsville, New Jersey

08070, made application by renewal to

the Drug Enforcement Administration

(DEA) for registration as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Methylphenidate (1724) ................ II

Amobarbital (2125) ....................... II

Pentobarbital (2270) ..................... II

Secobarbital (2315) ...................... II

Glutethimide (2550) ...................... II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

The firm plans to manufacture the

controlled substances for distribution as

bulk products to its customers. Any other such applicant and any

person who is presently registered with

DEA to manufacture such substance

may file comments or objections to the

issuance of the proposed registration. Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than April 10,

2000.

Dated: February 2, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–3147 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.33(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on October 24, 1999,

High Standard Products, 1100 W.

Florence Avenue, #B, Inglewood,

California 90301, made application by

renewal to the Drug Enforcement

Administration (DEA) for registration as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Methaqualone (2565) ................... I

Lysergic acid diethylamide (7315) I

Tetrahydrocannabinols (7370) ..... I

3,4-Methylenedioxyamphetamine

(7400).

I

3,4-Methylenedioxy-Nethylamphetamine (7404).I

Drug Schedule

3,4-

Methylenedioxymethamphetamine (7405).

I

4-Methoxyamphetamine (7411) ... I

Heroin (9200) ............................... I

3-Methylfentanyl (9813) ................ I

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

Secobarbital (2315) ...................... II

Phencyclidine (7471) .................... II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Hydromorphone (9150) ................ II

Diphenoxylate (9170) ................... II

Hydrocodone (9193) ..................... II

Methadone (9250) ........................ II

Morphine (9300) ........................... II

Fentanyl (9801) ............................ II

The firm plans to manufacture

analytical reference standards.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than April 10,

2000.

Dated: February 2, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–3148 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 1, 1999, and

published in the Federal Register on

October 13, 1999, (64 FR 55490), Irix

Pharmaceuticals, Inc., 101 Technology

Place, Florence, South Carolina 29501,

made application by renewal to the

Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of methylphenidate

(1724), a basic class of controlled

substance listed in Schedule II.

The firm plans to manufacture

methylphenidate for demonstration

purposes and for dosage form

development and stability studies.

DEA has considered the factors in

Title 21, United States Code, Section